Miravitlles M - Search Results

1

Changes in management of chronic obstructive pulmonary disease (COPD) in primary care: EMMEPOC study.

Soler N, Ballester E, Martín A, Gobartt E, Miravitlles M, Torres A. Soler N, et al. Among authors: miravitlles m. Respir Med. 2010 Jan;104(1):67-75. doi: 10.1016/j.rmed.2009.08.003. Respir Med. 2010. PMID: 20122630 Free article. Clinical Trial.

2

Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience.

Miravitlles M, Vidal R, Barros-Tizón JC, Bustamante A, España PP, Casas F, Martínez MT, Escudero C, Jardi R. Miravitlles M, et al. Respir Med. 1998 Oct;92(10):1181-7. doi: 10.1016/s0954-6111(98)90418-8. Respir Med. 1998. PMID: 9926146 Free article.

3

[Treatment of chronic bronchitis and chronic pulmonary obstructive disease in primary care].

Miravitlles M, Murio C, Guerrero T, Segú JL. Miravitlles M, et al. Arch Bronconeumol. 1999 Apr;35(4):173-8. doi: 10.1016/s0300-2896(15)30274-x. Arch Bronconeumol. 1999. PMID: 10330538 Spanish.

4

Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.

Miravitlles M, Mayordomo C, Artés M, Sánchez-Agudo L, Nicolau F, Segú JL. Miravitlles M, et al. Respir Med. 1999 Mar;93(3):173-9. doi: 10.1016/s0954-6111(99)90004-5. Respir Med. 1999. PMID: 10464874 Free article.

5

Interpretation of quality of life scores from the St George's Respiratory Questionnaire.

Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jiménez-Ruiz CA, Miravitlles M. Ferrer M, et al. Among authors: miravitlles m. Eur Respir J. 2002 Mar;19(3):405-13. doi: 10.1183/09031936.02.00213202. Eur Respir J. 2002. PMID: 11936515 Free article.

6

Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD.

Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Miravitlles M, et al. Chest. 2002 May;121(5):1449-55. doi: 10.1378/chest.121.5.1449. Chest. 2002. PMID: 12006427

7

Treatment and quality of life in patients with chronic obstructive pulmonary disease.

Miravitlles M, Alvarez-Sala JL, Lamarca R, Ferrer M, Masa F, Verea H, Zalacain R, Murio C, Ros F; IMPAC Study Group. Miravitlles M, et al. Qual Life Res. 2002 Jun;11(4):329-38. doi: 10.1023/a:1015520110663. Qual Life Res. 2002. PMID: 12086118

8

Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?

Miravitlles M. Miravitlles M. Eur Respir J Suppl. 2002 Jul;36:9s-19s. doi: 10.1183/09031936.02.00400302. Eur Respir J Suppl. 2002. PMID: 12168752 Free article. Review.

9

Rapid screening for alpha1-antitrypsin deficiency in patients with chronic obstructive pulmonary disease using dried blood specimens.

Rodriguez F, Jardí R, Costa X, Cotrina M, Galimany R, Vidal R, Miravitlles M. Rodriguez F, et al. Among authors: miravitlles m. Am J Respir Crit Care Med. 2002 Sep 15;166(6):814-7. doi: 10.1164/rccm.2203025. Am J Respir Crit Care Med. 2002. PMID: 12231490

10

[Use of the Internet in a multicenter study of chronic obstructive pulmonary disease in primary care. Pilot phase of the EFEMAP study].

Miravitlles M, Llor C, Naberan K, Cots JM; Estudio EFEMAP. Miravitlles M, et al. Arch Bronconeumol. 2002 Sep;38(9):427-30. doi: 10.1016/s0300-2896(02)75256-3. Arch Bronconeumol. 2002. PMID: 12237014 Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

684 results

Search Page

Filters